New York State Common Retirement Fund’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $29.2K | Hold |
3,600
| – | – | ﹤0.01% | 3089 |
|
|
2026
Q1 | $23K | Hold |
3,600
| – | – | ﹤0.01% | 2992 |
|
|
2025
Q4 | $21.4K | Hold |
3,600
| – | – | ﹤0.01% | 3080 |
|
|
2025
Q3 | $19.1K | Hold |
3,600
| – | – | ﹤0.01% | 3114 |
|
|
2025
Q2 | $12.3K | Hold |
3,600
| – | – | ﹤0.01% | 3151 |
|
|
2025
Q1 | $10.7K | Hold |
3,600
| – | – | ﹤0.01% | 3075 |
|
|
2024
Q4 | $11K | Hold |
3,600
| – | – | ﹤0.01% | 3107 |
|
|
2024
Q3 | $9.18K | Sell |
3,600
-27,400
| -88% | -$82.9K | ﹤0.01% | 3114 |
|
|
2024
Q2 | $101K | Buy |
+31,000
| New | +$136K | ﹤0.01% | 2822 |
|
|
2022
Q3 | – | Sell |
-252
| Closed | -$1K | – | 3407 |
|
|
2022
Q2 | $1K | Sell |
252
-28,147
| -99% | -$70K | ﹤0.01% | 3390 |
|
|
2022
Q1 | $82K | Hold |
28,399
| – | – | ﹤0.01% | 3070 |
|
|
2021
Q4 | $86K | Buy |
28,399
+9,358
| +49% | +$40.6K | ﹤0.01% | 3115 |
|
|
2021
Q3 | $133K | Buy |
19,041
+82
| +0.4% | +$614 | ﹤0.01% | 3048 |
|
|
2021
Q2 | $174K | Sell |
18,959
-2,115
| -10% | -$21.4K | ﹤0.01% | 3091 |
|
|
2021
Q1 | $205K | Sell |
21,074
-6,826
| -24% | -$76.2K | ﹤0.01% | 2823 |
|
|
2020
Q4 | $286K | Hold |
27,900
| – | – | ﹤0.01% | 2609 |
|
|
2020
Q3 | $282K | Hold |
27,900
| – | – | ﹤0.01% | 2501 |
|
|
2020
Q2 | $291K | Hold |
27,900
| – | – | ﹤0.01% | 2481 |
|
|
2020
Q1 | $235K | Buy |
27,900
+10,700
| +62% | +$104K | ﹤0.01% | 2381 |
|
|
2019
Q4 | $151K | Sell |
17,200
-12,500
| -42% | -$103K | ﹤0.01% | 2861 |
|
|
2019
Q3 | $320K | Hold |
29,700
| – | – | ﹤0.01% | 2544 |
|
|
2019
Q2 | $377K | Hold |
29,700
| – | – | ﹤0.01% | 2517 |
|
|
2019
Q1 | $1.15M | Hold |
29,700
| – | – | ﹤0.01% | 1882 |
|
|
2018
Q4 | $604K | Sell |
29,700
-25,392
| -46% | -$762K | ﹤0.01% | 2193 |
|
|
2018
Q3 | $2.53M | Buy |
55,092
+4,160
| +8% | +$201K | ﹤0.01% | 1558 |
|
|
2018
Q2 | $3.01M | Buy |
50,932
+10,134
| +25% | +$587K | ﹤0.01% | 1475 |
|
|
2018
Q1 | $2.78M | Sell |
40,798
-1,439
| -3% | -$108K | ﹤0.01% | 1462 |
|
|
2017
Q4 | $4.17M | Sell |
42,237
-2,555
| -6% | -$286K | 0.01% | 1306 |
|
|
2017
Q3 | $5.36M | Buy |
44,792
+12,545
| +39% | +$1.17M | 0.01% | 1195 |
|
|
2017
Q2 | $2.82M | Buy |
32,247
+1,446
| +5% | +$80.9K | ﹤0.01% | 1515 |
|
|
2017
Q1 | $1.15M | Buy |
30,801
+4,201
| +16% | +$153K | ﹤0.01% | 1955 |
|
|
2016
Q4 | $817K | Hold |
26,600
| – | – | ﹤0.01% | 2139 |
|
|
2016
Q3 | $1.78M | Sell |
26,600
-30,700
| -54% | -$1.55M | ﹤0.01% | 1716 |
|
|
2016
Q2 | $1.71M | Hold |
57,300
| – | – | ﹤0.01% | 1685 |
|
|
2016
Q1 | $1.68M | Hold |
57,300
| – | – | ﹤0.01% | 1690 |
|
|
2015
Q4 | $4.49M | Hold |
57,300
| – | – | 0.01% | 1272 |
|
|
2015
Q3 | $4.32M | Buy |
57,300
+6,318
| +12% | +$597K | 0.01% | 1276 |
|
|
2015
Q2 | $5.95M | Buy |
50,982
+49,894
| +4,586% | +$9.04M | 0.01% | 1253 |
|
|
2015
Q1 | $257K | Buy |
+1,088
| New | +$233K | ﹤0.01% | 2121 |
|
|
2014
Q4 | – | Sell |
-1,985
| Closed | -$474K | – | 2051 |
|
|
2014
Q3 | $474K | Buy |
+1,985
| New | +$408K | ﹤0.01% | 1990 |
|
Other funds holding PBYI
ACA
New York State Common Retirement Fund's PBYI Position: Q2 2026 in Review
New York State Common Retirement Fund held its Puma Biotechnology (PBYI) position steady in Q2 2026 at 3,600 shares worth $29.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3089.
New York State Common Retirement Fund first reported a position in PBYI in Q3 2014 and has held it in 40 quarters since. The position peaked at $5.95M in Q2 2015. 160 funds tracked by Wall St. Rank hold PBYI as of Q2 2026.
- New York State Common Retirement Fund held 3,600 shares of Puma Biotechnology worth $29.2K as of Q2 2026.
- New York State Common Retirement Fund left its Puma Biotechnology share count unchanged in Q2 2026.
- Puma Biotechnology made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #3089 holding.
- New York State Common Retirement Fund first reported a position in Puma Biotechnology in Q3 2014 and has held it in 40 quarters since.
- New York State Common Retirement Fund's Puma Biotechnology position peaked at $5.95M in Q2 2015.
- 160 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2026.
Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.